Zealand Pharma Statistics
Total Valuation
Zealand Pharma has a market cap or net worth of 4.92 billion. The enterprise value is 3.67 billion.
| Market Cap | 4.92B |
| Enterprise Value | 3.67B |
Important Dates
The next estimated earnings date is Thursday, August 14, 2025.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +16.16% |
| Shares Change (QoQ) | -0.20% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 60.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 5.04 |
| PS Ratio | 609.80 |
| PB Ratio | 4.09 |
| P/TBV Ratio | 4.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -21.38 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -20.76 |
Financial Position
The company has a current ratio of 25.10, with a Debt / Equity ratio of 0.05.
| Current Ratio | 25.10 |
| Quick Ratio | 24.39 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.32 |
| Interest Coverage | -40.02 |
Financial Efficiency
Return on equity (ROE) is -21.27% and return on invested capital (ROIC) is -14.88%.
| Return on Equity (ROE) | -21.27% |
| Return on Assets (ROA) | -13.97% |
| Return on Invested Capital (ROIC) | -14.88% |
| Return on Capital Employed (ROCE) | -16.20% |
| Revenue Per Employee | 20,960 |
| Profits Per Employee | -446,158 |
| Employee Count | 335 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.03 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 329 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zealand Pharma had revenue of 8.07 million and -171.77 million in losses. Loss per share was -2.50.
| Revenue | 8.07M |
| Gross Profit | 7.54M |
| Operating Income | -205.78M |
| Pretax Income | -172.44M |
| Net Income | -171.77M |
| EBITDA | -204.35M |
| EBIT | -205.78M |
| Loss Per Share | -2.50 |
Balance Sheet
The company has 1.24 billion in cash and 57.18 million in debt, giving a net cash position of 1.18 billion.
| Cash & Cash Equivalents | 1.24B |
| Total Debt | 57.18M |
| Net Cash | 1.18B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.20B |
| Book Value Per Share | 17.03 |
| Working Capital | 1.25B |
Cash Flow
In the last 12 months, operating cash flow was -175.02 million and capital expenditures -1.88 million, giving a free cash flow of -176.90 million.
| Operating Cash Flow | -175.02M |
| Capital Expenditures | -1.88M |
| Free Cash Flow | -176.90M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 93.39% |
| Operating Margin | -2,550.13% |
| Pretax Margin | -2,136.97% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Zealand Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.16% |
| Shareholder Yield | n/a |
| Earnings Yield | -3.49% |
| FCF Yield | -3.59% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zealand Pharma has an Altman Z-Score of 37.79.
| Altman Z-Score | 37.79 |
| Piotroski F-Score | n/a |